Ana S. Newton, Ph.D. is a postdoctoral researcher at the Jorgensen Lab in the Department of Chemistry at Yale University. Dr. Newton helps develop small inhibitors to treat cancer and HIV using both computational and synthetic skills. She is currently leading two collaborative research projects to design potent small molecule inhibitors of DNMT3B, a protein whose inhibition has been shown to reduce or eliminate cancer growth, and CXCR4, a G-protein-coupled receptor-associated with HIV.
Dr. Newton holds a Ph.D. in Medicinal Chemistry and a B.S. in Chemistry from the University of Lisbon.
Newton’s research has been recognized with awards such as the Melanoma Research Alliance postdoctoral research fellowship, São Paulo Advanced School of Chemistry, and the Fundação para a Ciência e Tecnologia Scholarship.